[ASAP] Molecular Recognition Study toward the Mitochondrial Electron Transport Chain Inhibitor Mubritinib and Human Serum Albumin 🔗 Access full article via ACS Molecular Pharmaceutics Molecular TherapeuticsDOI: 10.1021 / acs. Molpharmaceut. 3c00187. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
